United States v. Caronia
Second Circuit Holds that Prohibiting Truthful Off-Label Promotion of FDA-Approved Drugs by Pharmaceutical Representatives Violates First Amendment.
Comment on: 703 F.3d 149 (2d Cir. 2012)
- Volume 127
- Issue 2
- December 2013
Second Circuit Holds that Prohibiting Truthful Off-Label Promotion of FDA-Approved Drugs by Pharmaceutical Representatives Violates First Amendment.
Comment on: 703 F.3d 149 (2d Cir. 2012)